Sign in

CIK 0001662579

  • Non-accelerated filer
  • Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475617627
Phone
+1 617-231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 220 shares (grant or award)
  2. 4 Grant or award Director acquired 339 shares (grant or award)
  3. 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.98 ($569,666)
  4. 4 Open-market sale Director sold 755 shares at $37.19 ($28,078)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Other acquisition Director acquired 115,415 shares (other)
  14. 4 Other acquisition Director acquired 84,475 shares (other)
  15. 4 Open-market sale Director sold 755 shares at $37.12 ($28,026)
  16. 4 Option exercise Director acquired 711 shares (option exercise)
  17. 4 Grant or award Director acquired 233 shares (grant or award)
  18. 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $37.77 ($566,536)
  19. 4 Grant or award Director acquired 359 shares (grant or award)
  20. 4 Grant or award Director acquired 266 shares (grant or award)

Page 13 of 15 · 296 filings